Evidence map›Paper›PMID 14614139›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes.

Armindo Salvador, Michael A Savageau

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Disulfide reductase systems in liver.British journal of pharmacology · 2019
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Evolution of enzymes in a series is driven by dissimilar functional demands.Proceedings of the National Academy of Sciences of the United States of America · 2006
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Armindo SalvadorDepartment of Microbiology and Immunology, University of Michigan Medical School, 5641 Medical Sciences Building II, Ann Arbor, MI 48109-0620, USA.
Michael A Savageau

Funding

GENE CIRCUITS AND BIOCHEMICAL NETWORKSR01GM030054 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAVAGEAU, MICHAEL A · 1985 to 2015
$3.2M
NIGMS NIH HHS R01 GM030054NIGMS NIH HHS R01-GM30054
6 · The paper itself

Abstract

Why do the activities of some enzymes greatly exceed the flux capacity of the embedding pathways? This is a puzzling open problem in quantitative evolutionary design. In this work we investigate reasons for high expression of a thoroughly characterized enzyme: glucose 6-phosphate dehydrogenase (G6PD) in human erythrocytes. G6PD catalyses the first step of the pathway that supplies NADPH for antioxidant defense mechanisms. Normal G6PD activity far exceeds the capacity of human erythrocytes for a steady NADPH supply, which is limited upstream of G6PD. However, the distribution of erythrocyte G6PD activity in human populations reveals a selective pressure for maintaining high activity. To clarify the nature of this selective pressure, we studied how G6PD activity and other parameters in a model of the NADPH redox cycle affect metabolic performance. Our analysis indicates that normal G6PD activity is sufficient but not superfluous to avoid NADPH depletion and ensure timely adaptation of the NADPH supply during pulses of oxidative load such as those that occur during adherence of erythrocytes to phagocytes. These results suggest that large excess capacities found in some biochemical and physiological systems, rather than representing large safety factors, may reflect a close match of system design to unscrutinized performance requirements. Understanding quantitative evolutionary design thus calls for careful consideration of the various performance specifications that biological components/processes must meet in order for the organism to be fit. The biochemical systems framework used in this paper is generally applicable for such a detailed examination of the quantitative evolutionary design of gene expression levels in other systems.

Indexed as

Evolution, MolecularErythrocytesGene ExpressionGlucosephosphate DehydrogenaseGlucosephosphate Dehydrogenase DeficiencyHumansKineticsModels, BiologicalNADPOxidation-ReductionSelection, GeneticGlucosephosphate DehydrogenaseNADP

Identifiers

PMID14614139
PMCPMC283614

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.